What changed from existing technology?
This study used single-cell analysis to find a specific cell state linked to cancer progression in the voice box, which may help in developing new treatments.
This study identifies a new high-risk epithelial state associated with cancer progression, which was not previously described in laryngeal dysplasia.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 3
cted from patients with laryngeal dysplasia, carcinoma in situ, and invasive LSCC. Our analysis identified a set of fate-determining genes (e.g., NOC2L) gove
Abstract ↗d single‑cell RNA sequencing on tissues collected from patients with laryngeal dysplasia, carcinoma in situ, and invasive LSCC. Our analysis identified a set
Abstract ↗r and molecular determinants of malignant progression remain incompletely defined. To characterize transcriptional states associated with this transition
Abstract ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This finding could help in developing targeted therapies for patients with high-risk laryngeal dysplasia.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.